| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |